blog
media download page
Essay / Stem Cell Research as an Ethical Dilemma in Health Care and health care providers to understand the human body and develop new treatments for diseases, the use of stem cells, particularly those derived from embryos, remains a controversial issue. Although medicine contains many known principles and theories, there remain opportunities for experimentation, subject to ethical review. Science and research have enabled Americans to lead healthier lives, with many Americans living significantly longer than the previous generation. The purpose of this article is to examine the ethical dilemma surrounding stem cell research. This discussion will include introduction and background, analysis, proposed health system strategies, and health policy related to stem cell research and therapy. Say no to plagiarism. Get a tailor-made essay on “Why violent video games should not be banned”?Get the original essayIntroduction and background of stem cellsStem cell research is not new and began in the United States in the 1950s . Stem cells are the building blocks of normal growth and development. They are essential for the reconstruction and repair of damaged tissues. Many degenerative diseases such as degenerative retinal disease or osteoarthritis result from the dysfunction of a specific cell type, which has the potential to be treated with stem cell therapy. Stem cells have the ability to grow and adapt to perform a specialized function that is determined by where they are found in the tissue (differentiation). For example, liver cells placed in the liver will become part of the liver. Reisman and Adams explained that embryonic cells have not yet acquired a specific role and are therefore capable of differentiating and dividing to reproduce multiple copies of these cells with extreme efficiency. Analysis of the Stem Cell Dilemma Although stem cell research shows great promise, the use of embryonic stem cells poses an ethical dilemma for researchers and the public. The ethical dilemma centers on the question of when life begins. Proponents hope that stem cell research will be the answer to repairing organ and tissue damage caused by diseases such as Parkinson's disease, multiple sclerosis and type I diabetes. Opponents consider the use of embryonic stem cells to be unethical as a human embryo is a human individual at an early stage of development. Although opponents do not deny the potential benefits of using embryonic stem cells, the question arises whether the ends justify the means. Embryonic stem cells are pluripotent cells that can develop into all types of cells that make up the human body. Pluripotent stem cells can be obtained from fetal tissue after an abortion and, therefore, raise ethical and controversial dilemmas for those opposed to abortion. Likewise, the destruction of human embryos continues to be a major factor in slowing progress in the development and use of hESCs due to conflicts with the religion and beliefs of many individuals.However, the first provision of the Code of Ethics for Nurses calls for the protection, promotion and restoration of patients' health. The rights of the sick patient must be taken into account and must allow easy access to the benefits of stem cell therapy to cure terminal illness. The argument here is that more lives will be saved using embryonic stem cell donations. recipients. Consent forms are collected from the donor and recipient. These consent forms must contain all identified risks, benefits and alternatives to the procedure. Advanced Practice Registered Nurses (APRN) and Doctor of Nursing Practice (DNP) have a responsibility to safeguard the integrity of individuals and adopt a process that respects the values and desires for fairness of all involved in the stem cell. process. Provisions seven and eight of the code of conduct call for nurses' participation in research and professional development to ensure quality health care and reduce health disparities. Two ethical principles to remember here are benevolence and non-maleficence. This would include providing compassionate care with autonomy to make an informed decision and avoid harming others based on our individual beliefs and values. Three of the essential DNPs guide APRNs to participate in evidence-based practices (EBPs) that would ensure health promotion and disease. prevention of all individuals in the community. We also know that EBP is about integrating the best research evidence and clinical expertise with patient needs in mind to provide quality, safe and cost-effective healthcare, excellent customer service and optimal outcomes. However, translating research to practice settings and integrating EBP into nursing practice has been a challenge. Studies have shown that nurses' cultural beliefs hinder this implementation in many healthcare settings. In general, nurses have a positive attitude toward evidence-based practice; however, this behavior should be eliminated to allow EBP to become a daily practice for the benefit of all patients. Federal funding and restrictions should be monitored and controlled to safeguard social justice and equity. A group or committee may develop guidelines and monitor stem cell research and therapy so that they are conducted in a socially just manner and promote and ensure essential elements of social justice. Individuals with a utilitarian approach seek to maintain social justice based on the effect an intervention would have on community members. They will select the intervention that would benefit the majority. A libertarian individual recognizes the right to life, liberty and property and respects the rights of others. They ensure that all services are available regardless of social and economic status and that denials of services are not based on race, ethnicity, or politics when treatment is necessary to save life. The third provision of the Code of Conduct calls on the nurse to promote and advocate for the health and safety of all patients. The goal should therefore be to make stem cell research and therapy accessible to everyone. The cost of integrating stem cell research and therapies into clinical practice is high, but it is a resource that should be allocated and distributed in a way that benefits all.This will require the DNP to participate in ongoing monitoring and pay attention to policies and practices to ensure fair and ethical use. Health Policy Regulating and Resolving Dilemmas Congressional hearings and public meetings of government agencies, as well as media coverage, have pushed stem cell research issues to the forefront. in the spotlight with high expectations. Stem cell research and technology has exploded in recent years, since embryonic cells were first isolated in 1998. The role of each agency is slightly different, but all contribute by providing the infrastructure necessary for or influencing stem cell research. In the United States, research abuses guided the National Strengthening in 1974, which created the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. In 1978, the Commission published the Ethical Principles and Guidelines for the Protection of Human Subjects of Research, also known as the Belmont Report. This identified three fundamental ethical principles for all human research to ensure respect for individuals, beneficence, non-maleficence and justice. The term beneficence is defined as trying to help others and nonmaleficence to require individuals not to harm others. The infrastructure for stem cell projects rests with the National Institute of Health (NIH). All acceptable stem cell research must be submitted, listed, and approved by the NIH. The subcomponents of the NIH are the Centers or Research Resource Organizations (NCRRO), the Institute on Aging (NIA), the Institute of Child Health and Human Development (NICHD), and the Diabetes Institute and digestive and kidney diseases (NIDDK). Within these various subcomponents is the actual process of developing cures for serious illnesses that affect Americans every day. With the increasing use of human embryonic stem cells (hESCs) to understand and treat degenerative diseases, some individuals have opposed the idea. to destroy human embryos. In response, in 2001, President Bush signed a bill authorizing federal National Institutes of Health (NIH) funding of stem cell research only for embryonic stem cell lines produced before 2001. This constituted a major incentive to involve more researchers in stem cell research. increase the chances of therapeutic breakthroughs to cure diseases that would regularly kill individuals. In cases involving blastocysts, gametes, and somatic cells for research purposes, the procurement process requires approval from an Institutional Review Board (IRB). The composition and functions of the IRB are described in the Department of Health and Human Services (DHHS) regulations at 45 CFR 46.107-115. The mission of DHHS is to protect human research subjects and extend its protection to vulnerable populations such as pregnant women, viable fetuses, prisoners, and children. The Food and Drug Administration Center (FDA) regulates cells, tissues, and human cells and tissues. products based on organic products for the purposes of evaluation and research on organic products. This covers all purposes of implantation, transplantation, infusion or transfer into a human recipient, including stem cells. Keep in mind: this is just a sample. Get a personalized item now from our.21666
Navigation
« Prev
1
2
3
4
5
Next »
Get In Touch